Australia TGA ARTG record

Orthopaedic implant/trial-implant holder

Australia TGA ARTG Registered Device · LC & Partners Pty Ltd · Groupe Lepine · Class IIa · Started March 24, 2023

Good Name: LC & Partners Pty Ltd - Orthopaedic implant/trial-implant holder

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: March 24, 2023
Effective Date: March 24, 2023

Sponsor

Name: LC & Partners Pty Ltd

Manufacturer

Name: Groupe Lepine
Country: France
Address: 175 rue Jacquard CS 50307, Genay, Cedex, 69727

Intended purpose

- These instruments are intended to place the related implants manufactured by groupe lépine. - The expected clinical benefits for the patient correspond to the clinical benefits of the associated implants. - The usage details concerning these devices are described in the associated surgical techniques for each implant range to hand, wrist, hip, knee arthroplasty or to osteosynthesis. - These instruments must be used in association with implants from groupe lépine. It should not be used for another application.

About this record

Access comprehensive regulatory information for Orthopaedic implant/trial-implant holder in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by LC & Partners Pty Ltd, manufactured by Groupe Lepine in France. The device registration started on March 24, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.